{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:46Z","timestamp":1791235366008,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.bulcan.2015.01.006","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T01:48:51Z","timestamp":1424915331000},"page":"256-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Les facteurs de risque g\u00e9n\u00e9tiques et environnementaux des cancers de l\u2019endom\u00e8tre"],"prefix":"10.1016","volume":"102","author":[{"given":"Claire","family":"S\u00e9n\u00e9chal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Cottereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"de Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Elan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dagousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fourchotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gauthier-Villars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marick","family":"Lae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Buecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2015.01.006_bib0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007\u00a0by country and age: results of EUROCARE-5 \u2013 a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.respe.2013.11.073","article-title":"Cancer incidence and mortality in France aver the 1980\u20132012\u00a0period: solid tumors","volume":"62","author":"Binder-Foucard","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1684\/bdc.2011.1526","article-title":"Anatomopathologie des cancers de l\u2019endom\u00e8tre","volume":"99","author":"Albertini","year":"2012","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1684\/bdc.2011.1524","article-title":"Recommandations professionnelles pour le cancer de l\u2019endom\u00e8tre 2010\u00a0: utilisation pratique et questions encore \u00e9mergentes","volume":"99","author":"Uzan","year":"2012","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0220","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0225","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/sj.bjc.6603731","article-title":"Reproductive risk factors for endometrial cancer among Polish women","volume":"96","author":"Brinton","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0230","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.25050","article-title":"Reproductive risk factors and endometrial cancer: the European prospective investigation into cancer and nutrition","volume":"127","author":"Dossus","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0235","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0240","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJM198510173131601","article-title":"Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens","volume":"313","author":"Shapiro","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0245","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/aje\/kwu146","article-title":"Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992\u20132008","volume":"180","author":"Fournier","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0250","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intra-uterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0255","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2013.11.012","article-title":"Bariatric surgery decreases the risk of uterine malignancy","volume":"133","author":"Ward","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0265","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: a meta-analysis","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0270","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ygyno.2012.03.032","article-title":"Insulin resistance: a significant risk factor of endometrial cancer","volume":"125","author":"Mu","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres\u2019 ALERT Group. Assessment of liver and endometrial cancer risk following Tamoxifen","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0280","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7150\/jca.8412","article-title":"Endometrial cancer incidence in breast cancer patients correlating with age and duration of tamoxifen use: a population based study","volume":"5","author":"Chen","year":"2014","journal-title":"J Cancer"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0285","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ejso.2014.05.007","article-title":"Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363\u00a0patients","volume":"40","author":"Ng\u00f4","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0290","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0295","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2014.03.011","article-title":"Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?","volume":"133","author":"Bharati","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0300","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1684\/bdc.2011.1522","article-title":"Cancers de l\u2019endom\u00e8tre et pr\u00e9disposition","volume":"99","author":"Caron","year":"2012","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0305","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6\u00a0genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0310","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary non polyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0315","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0320","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1200\/JCO.2008.18.6296","article-title":"Carcinoma of the lower uterine segment: a newly described association with Lycnh syndrome","volume":"26","author":"Westin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0325","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of Euopean experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0330","series-title":"Genetic\/familial high-risk assessment: Colorectal Version I","author":"Clinical Practice Guidelines in Oncology NCCN (NCCN Guidelines\u00ae)","year":"2014"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0335","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/1940-6207.CAPR-13-0359","article-title":"Evaluation of clinical criteria for the identification of Lynch Syndrome among unselected endometrial cancer patients","volume":"7","author":"Bruegl","year":"2014","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0340","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer","volume":"25","author":"Lu","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0345","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2014.03.012","article-title":"The results of gynecologic surveillance in families with hereditary non polyposis colorectal cancer","volume":"133","author":"Ketabi","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0350","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.22446","article-title":"Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome","volume":"120","author":"Renkonen-Sinisalo","year":"2007","journal-title":"Int J Cancer"},{"issue":"Suppl. 6","key":"10.1016\/j.bulcan.2015.01.006_bib0355","doi-asserted-by":"crossref","first-page":"vi73","DOI":"10.1093\/annonc\/mdt209","article-title":"Familial colorectal cancer risk: ESMO clinical practice guidelines","volume":"24","author":"Balmana","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0360","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/his.12386","article-title":"Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations of grossing","volume":"65","author":"Downes","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0365","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","article-title":"Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus Depo-Provera for prevention of endometrial cancer in women with Lynch Syndrome","volume":"6","author":"Lu","year":"2013","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0370","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2\u00a0randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1684\/bdc.2011.1521","article-title":"Place de la pr\u00e9servation ovarienne dans le traitement des carcinomes endom\u00e9triaux de stades pr\u00e9coces","volume":"99","author":"Poilblanc","year":"2012","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0380","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng.2503","article-title":"Germline mutations affecting the proofreading domains of POLE and POLD1\u00a0predispose to colorectal adenomas and carcinoma","volume":"45","author":"Palles","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0385","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1093\/hmg\/ddt131","article-title":"DNA polymerase \u025b and \u03b4 exonuclease domain mutations in endometrial cancer","volume":"22","author":"Church","year":"2013","journal-title":"Human Mol Genet"},{"key":"10.1016\/j.bulcan.2015.01.006_bib0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10689-014-9722-7","article-title":"Genetics of endometrial cancer","volume":"13","author":"Shai","year":"2014","journal-title":"Fam Cancer"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T12:07:42Z","timestamp":1717762062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0007455115000442"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.01.006","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les facteurs de risque g\u00e9n\u00e9tiques et environnementaux des cancers de l\u2019endom\u00e8tre","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}